Genius Sports Limited
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Second Spectrum Restricted Shares
On June 15, 2021, as part of the Company’s acquisition of Second Spectrum (See Note 3 – Business Combinations), the Company granted 518,706 restricted shares to the founders of Second Spectrum, with 50% to be vested on December 31, 2021 and 2022 (“Second Spectrum Restricted Shares”). The grant date fair value of the Second Spectrum Restricted Shares is estimated to be equal to the closing price of the Company’s common stock of $17.74 as of the grant date on June 15, 2021.
A summary of the Company’s overall restricted shares activities for the six months ended June 30, 2021 is as follows:
| | | | | | | | |
| | Number of Shares | | | Weighted Average Grant Date Fair Value per Share | |
Unvested restricted shares as of December 31, 2020 | | | — | | | | | |
Granted | | | 10,948,715 | | | $ | 8.66 | |
Vested | | | 216,409 | | | $ | 8.62 | |
| | | | | | | | |
Unvested restricted shares as of June 30, 2021 | | | 10,732,306 | | | $ | 8.66 | |
| | | | | | | | |
The compensation cost recognized for the restricted shares during the three and six months ended June 30, 2021 and 2020 were $215.5 million and zero, respectively.
As of June 30, 2021, total unrecognized compensation cost related to the restricted shares was $78.2 million and is expected to be recognized over a weighted-average service period of 1.7 years.
Stock Options
2021 Option Plan
On April 20, 2021 (“Grant Date”), as part of the Merger, the Board of Directors adopted the 2021 Option Plan and granted employees options to purchase the Company’s common stock via an employee benefit trust including 1) options which shall immediately vest upon Closing (“Immediate-Vesting Options”), 2) options subject only to service conditions (“Time-Vesting Options”) and 3) options with service and market conditions (“Performance-Vesting Options”). Immediate-Vesting Options became fully vested and exercisable immediately following the Closing, which aligns with the Grant Date. Time-Vesting Options are subject to graded vesting over the four years following the Grant Date. Performance-Vesting Options are subject to graded vesting over the three years from the Grant Date, subject to a market condition related to volume weighted average trading price performance of the Company’s common stock.
The estimated Grant Date fair value of the Company’s options under the 2021 Option Plan was calculated using a combination of the Black Scholes Option Pricing Model and Monte Carlo simulations based on the following assumptions:
| | | | |
Time to maturity (1) | | | 5 | years |
Common stock price (2) | | $ | 16.21 | |
Volatility (3) | | | 90.1 | % |
Risk-free rate (4) | | | 0.8 | % |
Strike price (1) | | $ | 10.00 | |
Dividend yield (5) | | | 0.0 | % |
(1) | Based on contractual terms |
(2) | Represents the publicly traded common stock price as of the Grant Date |
(3) | Calculated based on comparable companies’ historical volatilities over a matching term of 5 years |
(4) | Based on the U.S. Constant Maturity Treasury yield curve as of the valuation date over a matching term over 5 years |
(5) | Assumes a dividend yield of zero as the Company has no plans to declare dividends in the foreseeable future |
A summary of the Company’s options activity for the six months ended June 30, 2021 is as follows:
| | | | | | | | | | | | | | | | |
| | Number of Options | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Life | | | Aggregate Intrinsic Value | |
| | | | | | | | (in years) | | | (in thousands) | |
Outstanding as of December 31, 2020 | | | — | | | | — | | | | | | | | | |
Granted | | | 445,868 | | | $ | 10.00 | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Outstanding as of June 30, 2021 | | | 445,868 | | | $ | 10.00 | | | | 4.81 | | | $ | 3,911 | |
| | | | | | | | | | | | | | | | |
Exercisable as of June 30, 2021 | | | 58,053 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Unvested as of June, 30, 2021 | | | 387,815 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
The compensation cost recognized for options during the three and six months ended June 30, 2021 was $0.7 million. The weighted-average grant date fair value per share of options granted during the three and six months ended June 30, 2021 was $10.10. The total fair value of options that vested during the three and six months ended June 30, 2021 was $0.5 million.
As of June 30, 2021, the Company had $3.8 million of unrecognized stock-based compensation expense related to the stock options. This cost is expected to be recognized over a weighted-average period of 3.58 years.
NFL Warrants
On April 1, 2021, the Company entered into a new multi-year strategic partnership with NFL Enterprises LLC (“NFL”) (the “License Agreement”). Under the terms of the License Agreement, the Company obtains the right to serve as the worldwide exclusive distributor of NFL official data to the global regulated sports betting market, the worldwide exclusive distributor of NFL official data to the global media market, the NFL’s exclusive international distributor of live digital video to the regulated sports betting market (outside of the United States where permitted), and the NFL’s exclusive sports betting and i-gaming advertising partner. The License Agreement contemplates a six-year period (the “Term”), with an initial four-year period commencing April 1, 2021 and years five and six renewable by NFL in one year increments. Pursuant to the License Agreement, the Company, agreed to issue the NFL an aggregate of up to 18,500,000 warrants and 2,000,000 additional warrants for each annual extension, with each warrant entitling NFL to purchase one ordinary share of the Company for an exercise price of $0.01 per warrant share. The warrants will be subject to vesting over the six-year Term. Additionally, each warrant is issued with one share of redeemable B Share with a par value of $0.0001. The B Shares, which are not separable from the warrants, are voting only shares with no economic rights to dividends or distributions. Pursuant to the License Agreement, when the warrants are exercised, the Company shall purchase or, at its discretion, redeem at the par value an equivalent number of B Shares, and any such purchased or redeemed B Shares shall thereafter be cancelled.
The Company accounts for the License Agreement as an executory contract for the ongoing Data Feeds and the warrants will be accounted for as share-based payments to non-employees. The awards are measured at grant date fair value when all key terms and conditions are understood by both parties, including for unvested awards and are expensed over the term to align with the data services to be provided over the periods.
The grant date fair value of the warrants is estimated to be equal to the closing price of dMY’s common stock of $15.63, as of the grant date on April, 1, 2021. The Company used dMY’s stock price to approximate the fair value of the Company as the grant date was before the Merger was consummated.
A summary of the Company’s warrants activity for the six months ended June 30, 2021 is as follows:
| | | | | | | | |
| | Number of Warrants | | | Exercise Price | |
Outstanding as of December 31, 2020 | | | — | | | | — | |
Issued | | | 18,500,000 | | | $ | 0.01 | |
| | | | | | | | |
Outstanding as of June 30, 2021 | | | 18,500,000 | | | | | |
| | | | | | | | |
The cost recognized for the warrants during the three and six months ended June 30, 2021 and 2020 was $198.3 million. As of June 30, 2021, the Company had $90.8 million of unrecognized stock-based compensation expense related to the warrants. The warrants vest over a three year period and the cost is expected to be recognized over a weighted-average period of 1.20 years. 11,250,000 warrants were vested in the three and six months ended June 30, 2021.
17